Literature DB >> 22096435

Chondrosarcoma of the spine: a series of 16 cases and a review of the literature.

Sophia A Strike1, Edward F McCarthy.   

Abstract

Only a few major studies of chondrosarcoma of the mobile spine have been reported. These studies have shown that spinal chondrosarcomas require complete surgical resection and are notoriously resistant to chemotherapy and radiation. We present 16 cases of chondrosarcoma of the mobile spine diagnosed at a median age of 54.5 (range 20 - 79) years. Diagnosis and treatment studies were based on both CT scans and MRI. Fifteen of our 16 patients had low-grade (grade 1-2) chondrosarcomas. All patients were treated with surgical resection. Fourteen patients had total resection while two patients had subtotal resection. The two patients who had subtotal resection died of their disease. Five of the fourteen patients who had total resection also died. The mean interval to death was 3.6 years. This study confirms that although chondrosarcomas of the spine are low grade, they are dangerous neoplasms. Even with complete resection, they have a high rate of recurrence and metastasis.

Entities:  

Mesh:

Year:  2011        PMID: 22096435      PMCID: PMC3215129     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  16 in total

Review 1.  Differential diagnosis of primary malignant bone tumors in the spine and sacrum. The radiological and clinical spectrum: minireview.

Authors:  S M Knoeller; M Uhl; N Gahr; C P Adler; G W Herget
Journal:  Neoplasma       Date:  2008       Impact factor: 2.575

Review 2.  Primary malignant tumors of the spine.

Authors:  Narayan Sundaresan; Gerald Rosen; Stefano Boriani
Journal:  Orthop Clin North Am       Date:  2009-01       Impact factor: 2.472

3.  Chondrosarcoma of the spine: 1954 to 1997.

Authors:  J E York; R H Berk; G N Fuller; J S Rao; D Abi-Said; D M Wildrick; Z L Gokaslan
Journal:  J Neurosurg       Date:  1999-01       Impact factor: 5.115

4.  Chondrosarcoma of the mobile spine: report on 22 cases.

Authors:  S Boriani; F De Iure; S Bandiera; L Campanacci; R Biagini; M Di Fiore; L Bandello; P Picci; P Bacchini
Journal:  Spine (Phila Pa 1976)       Date:  2000-04-01       Impact factor: 3.468

5.  Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.

Authors:  P Bergh; B Gunterberg; J M Meis-Kindblom; L G Kindblom
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

6.  Surgical management of primary and metastatic sarcoma of the mobile spine.

Authors:  Ganesh Rao; Dima Suki; Indro Chakrabarti; Iman Feiz-Erfan; Milan G Mody; Ian E McCutcheon; Ziya Gokaslan; Shreyaskumar Patel; Laurence D Rhines
Journal:  J Neurosurg Spine       Date:  2008-08

7.  Primary spinal chondrosarcoma: radiologic findings with pathologic correlation.

Authors:  I Lloret; A Server; B Bjerkehagen
Journal:  Acta Radiol       Date:  2006-02       Impact factor: 1.990

8.  Chondrosarcoma of the spine.

Authors:  T C Shives; R A McLeod; K K Unni; M F Schray
Journal:  J Bone Joint Surg Am       Date:  1989-09       Impact factor: 5.284

9.  Primary intradural mesenchymal chondrosarcoma of the spine in a child.

Authors:  Yu-Hua Li; Xiao-Hong Yao
Journal:  Pediatr Radiol       Date:  2007-09-12

10.  Chondrosarcoma of the spine: a rare case with unusual presentation.

Authors:  John Panelos; Spyridon Voulgaris; Evangelos Michos; Michael Doukas; Konstantinos Charalabopoulos; Anna Batistatou
Journal:  Diagn Pathol       Date:  2006-10-30       Impact factor: 2.644

View more
  15 in total

1.  Chondrosarcoma arising within synovial chondromatosis of the lumbar spine.

Authors:  Laurel A Littrell; Carrie Y Inwards; Peter S Rose; Doris E Wenger
Journal:  Skeletal Radiol       Date:  2019-02-05       Impact factor: 2.199

Review 2.  Interventional Therapies for Pain in Cancer Patients: a Narrative Review.

Authors:  David Hao; Shawn Sidharthan; Juan Cotte; Mary Decker; Mariam Salisu-Orhurhu; Dare Olatoye; Jay Karri; Jonathan M Hagedorn; Peju Adekoya; Charles Odonkor; Amitabh Gulati; Vwaire Orhurhu
Journal:  Curr Pain Headache Rep       Date:  2021-05-07

3.  Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center.

Authors:  Kehan Xu; Bo Li; Quan Huang; Dongjie Jiang; Haitao Sun; Nanzhe Zhong; Wei Wan; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2019-05-04       Impact factor: 3.134

4.  Imaging features of synovial chondromatosis of the spine: a review of 28 cases.

Authors:  Laurel A Littrell; Carrie Y Inwards; Franklin H Sim; Doris E Wenger
Journal:  Skeletal Radiol       Date:  2015-09-12       Impact factor: 2.199

5.  Chondrosarcoma of the spine-a case report.

Authors:  Sebastian Simon; Heinrich Resch; Friedrich Lomoschitz; Bernhard J H Frank; Roland Kocijan
Journal:  Wien Med Wochenschr       Date:  2022-02-04

6.  A Rare and Interesting Case of a Massive Secondary Spinal Chondrosarcoma and Review of the Literature.

Authors:  Anthony Adimonye
Journal:  Case Rep Orthop       Date:  2015-05-03

7.  Chondrosarcoma in a paediatric population: a study of 247 cases.

Authors:  A-M Wu; G Li; J-W Zheng; C-H Chen; D Chen; Z-G Qiao; J-G Zhao; B Wang; W-L Fu; S-R Sheng; Y-S Wu; N-F Tian; Z-K Lin; H Xu
Journal:  J Child Orthop       Date:  2019-02-01       Impact factor: 1.548

8.  Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma.

Authors:  Nuno Rui Paulino Pereira; Stein J Janssen; Nicky Stoop; Stefan Hartveldt; Yen-Lin E Chen; Thomas F DeLaney; Francis J Hornicek; Joseph H Schwab
Journal:  Global Spine J       Date:  2019-02-18

9.  Chondrosarcoma of the dorsal spine - A rare case.

Authors:  Mihir Mohan Vaidya; Asha Sharad Shenoy; Naina Atul Goel
Journal:  J Craniovertebr Junction Spine       Date:  2020-01-23

10.  Novel prognostication of patients with spinal and pelvic chondrosarcoma using deep survival neural networks.

Authors:  Sung Mo Ryu; Sung Wook Seo; Sun-Ho Lee
Journal:  BMC Med Inform Decis Mak       Date:  2020-01-06       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.